Exclusive

Publication

Byline

Location

Clinical Trial: Optimization of Emergency Treatment Strategies and Prognosis Evaluation for Bacillus cereus Endophthalmitis (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimization of Emergency Treatment Strategies and Prognosis Evaluation for Bacillus ce... Read More


Clinical Trial: Development of an Advance Care Planning Education Program for Adults with Elderly Parents (Japan)

Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062597) titled 'Advance Care Planning Workshop for Adult Children of Elderly Parents' on Au... Read More


Clinical Trial: Effects of light touch on postural stability and its neurophysiological mechanisms in older adults (Japan)

Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062594) titled 'A study of the effects of light touch on standing balance in older adults' ... Read More


Clinical Trial: Effect of Intermittent Leg Fidgeting on Daily Time in Tight Range (TITR) in Young Adults with Postprandial Glucose Spikes: A Randomized Crossover Trial (Japan)

Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062591) titled 'Effect of Intermittent Leg Fidgeting on Daily Time in Tight Range (TITR) in... Read More


Clinical Trial: A multicenter prospective observational study of the effectiveness and safety of first-line amivantamab plus lazertinib combination therapy in EGFR-mutated non-small cell lung cancer (Japan)

Tokyo, Aug. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062590) titled 'A study of the effectiveness and side effects of first-line amivantamab plu... Read More


Clinical Trial: A Comparison of the Incidence of Postdischarge Nausea and Vomiting (PDNV) Following Outpatient Nasal and Sinus Surgery Using Remimazolam and Sevoflurane: A Multicenter, Prospective, Randomized Controlled Trial (Japan)

Tokyo, Aug. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062448) titled 'A Comparison of the Incidence of Postdischarge Nausea and Vomiting' on Aug.... Read More


Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More


Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More